drugset / Trial / NCT00544063

Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer

NCT00544063 ↗

Non-randomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as capecitabine, irinotecan, and oxaliplatin, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. PURPOSE: This phase I trial is studying the side effects and best dose of capecitabine when given together with irinotecan and oxaliplatin in treating patients with metastatic cancer.

Timeline

Start
2006-10
Primary completion
2011-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule — Intravenous
Subject Oxaliplatin Small molecule — Intravenous